Verrica Pharmaceuticals Inc.
VRCA
|
|
| |
|
| Trading Volume | 6,725 |
|
|
9.13 - 2.34 |
| Market Cap Full | $ 103.5M |
Quarterly +
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Q1 | 0.3% | -19.1% | 136.4% | -11.5% |
| Q2 | - | 21.7% | -11.2% | -76.3% |
| Q3 | - | -62.9% | -32.7% | 52.1% |
| Q4 | - | -26.4% | 82.5% | -5.8% |
Monthly +
| J | F | M | A | M | J | J | A | S | O | N | D |
| 2025 | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.3 | - | - | - | - | - | - | - | - | - | - | - |
| 2024 | |||||||||||
| -22.8 | -6.7 | 12.3 | 15.2 | 25.1 | -15.7 | -8 | -62.9 | - | - | - | - |
| 2023 | |||||||||||
| 68 | 67.8 | -16.1 | -5.1 | -8.1 | 1.8 | 1.2 | -22.1 | -14.6 | -5.3 | - | 98.9 |
| 2022 | |||||||||||
| -10.6 | -2.3 | 1.4 | -17.1 | -71.6 | 0.5 | 64.1 | 24.4 | -25.5 | -14.7 | 30.5 | -15.4 |
| 2021 | |||||||||||
| 1.6 | 23.3 | 4.3 | -11.5 | -16 | 0.4 | -5.3 | 4.7 | 11.6 | 0.7 | -17.8 | -11.5 |
| 2020 | |||||||||||
| -10 | -14.7 | -10.4 | 10.4 | -4.9 | -4.1 | -40.4 | 40.1 | -15.8 | -4.3 | 23.5 | 26.8 |
EPS
| 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|
| Q1 | -0.2 | -0.3 | -0 | -0.4 |
| Q2 | -0.2 | -0.4 | -0.4 | -0.4 |
| Q3 | -0.5 | 0 | -0.5 | -0.4 |
| Q4 | 0 | -0 | -0.4 | -0.5 |
| A | -0.93 | -0.7 | -1.3 | -1.7 |